Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Dr. Falk Pharma GmbH, Leinenweberstr. 5, 79108, Freiburg, Germany
Budenofalk 3 mg gastro-resistant capsules.
| Pharmaceutical Form |
|---|
|
Gastro-resistant capsules, hard (gastro-resistant capsules). Capsule, hard, pink containing white gastro-resistant granules. |
Each capsule contains 3 mg budesonide.
Excipients with known effect: each capsule contains 240 mg sucrose and 12 mg lactose monohydrate.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Budesonide |
Budesonide is a glucocorticosteroid with a high local anti-inflammatory effect. At doses clinically equivalent to systemically acting glucocorticosteroids, budesonide gives significantly less HPA axis suppression and has a lower impact on inflammatory markers. |
| List of Excipients |
|---|
|
Capsule contents: Ammonio methacrylate copolymer (type A) (Eudragit RL) * intermediate excipient Capsule shell: Black iron oxide (E172) |
Al/PVC/PVDC blister strips.
Pack sizes: 10, 50, 90, 100 or 120 capsules.
Not all pack sizes may be marketed.
Dr. Falk Pharma GmbH, Leinenweberstr. 5, 79108, Freiburg, Germany
PL 08637/0002
04/01/2009
| Drug | Countries | |
|---|---|---|
| BUDENOFALK | Australia, Cyprus, Estonia, Finland, Hong Kong, Ireland, Lithuania, Netherlands, Poland, Romania, Singapore, Turkey, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
